**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 6080-56-4 |Acetic acid, lead(2+) salt trihydrate | 100 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T N
Risk Phrases: 33 48/22 61 62 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Danger of cumulative effects. Harmful : danger of serious damage to
health by prolonged exposure if swallowed. May cause harm to the
unborn child. Possible risk of impaired fertility. Very toxic to
aquatic organisms, may cause long-term adverse effects in the
aquatic environment.Air sensitive.
Potential Health Effects
Eye:
May result in corneal injury. May cause irreversible eye injury.
Exposure to particulates or solution may cause conjunctivitis,
ulceration, and corneal abnormalities.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause kidney damage.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Chronic exposure may cause blood effects. May cause kidney damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of Calcium disodium EDTA as a chelating agent should be
determined by qualified medical personnel. The use of
d-Penicillamine as a chelating agent should be determined by
qualified medical personnel. The use of Dimercaprol or BAL (British
Anti-Lewisite) as a chelating agent should be determined by qualified
medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Water runoff can cause environmental damage. Dike
and collect water used to fight fire. Dusts at sufficient
concentrations can form explosive mixtures with air. During a fire,
irritating and highly toxic gases may be generated by thermal
decomposition or combustion.
Extinguishing Media:
Use alcohol foam, carbon dioxide, or water spray when fighting fires
involving this material.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
Place under an inert atmosphere.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Wash hands before eating. Use with
adequate ventilation. Minimize dust generation and accumulation. Do
not get in eyes, on skin, or on clothing. Keep container tightly
closed. Handle under an inert atmosphere. Store protected from air.
Wash clothing before reuse.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep containers tightly closed. Do not expose to air.
Store under an inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower.
Exposure Limits
CAS# 301-04-2:
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
CAS# 6080-56-4:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
CAS# 7439-92-1:
United Kingdom, WEL - TWA: 0.15 mg/m3 TWA
United Kingdom, WEL - STEL: 0.45 mg/m3 TWA
United States OSHA: ; 50 ??g/m3 PEL (as Pb); 30 ??g/m3 Action Level
Pb. Poison - see 29 CFR 1910.10 25)
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: 0.1 mg/m3 VME
Germany: 0.1 mg/m3 TWA (inhalable fraction)
Japan: 0.1 mg/m3 OEL
Malaysia: 0.05 mg/m3 TWA
Netherlands: 0.15 mg/m3 MAC
Russia: 0.01 mg/m3 TWA
Russia: 0.005 mg/m3 STEL
Spain: 0.15 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: acetic odor - weak odor
pH: 5.5-6.5 (5% aq soln)
Vapor Pressure: 0 atm at 30 C
Viscosity: Not available.
Boiling Point: decomposes
Freezing/Melting Point: 75 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 200 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 2.55
Molecular Formula: Pb(C2H3O2)2.3H2O
Molecular Weight: 379.2798
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. Takes up CO2 from air and becomes
incompletely soluble. Slowly effloresces (loses water molecules of
hydration) on exposure to air.
Conditions to Avoid:
Dust generation, exposure to air, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, lead/lead oxides.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 301-04-2: AI5250000
CAS# 6080-56-4: OF8050000
CAS# 7439-92-1: OF7525000
LD50/LC50:
Not available.
CAS# 6080-56-4: Oral, rat: LD50 = 4665 mg/kg.
CAS# 7439-92-1.
Carcinogenicity:
Lead acetate anhydrous -
California: carcinogen, initial date 1/1/88
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Acetic acid, lead(2+) salt trihydrate -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
Lead -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 10/1/92
NTP: Suspect carcinogen
IARC: Group 2B carcinogen
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD ACETATE
Hazard Class: 6.1
UN Number: 1616
Packing Group: III
IMO
Shipping Name: LEAD ACETATE
Hazard Class: 6.1
UN Number: 1616
Packing Group: III
RID/ADR
Shipping Name: LEAD ACETATE
Hazard Class: 6.1
UN Number: 1616
Packing group: III
USA RQ: CAS# 301-04-2: 10 lb final RQ; 4.54 kg final RQ
USA RQ: CAS# 7439-92-1: 10 lb final RQ (no reporting of releases of this hazardo
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 33 Danger of cumulative effects.
R 48/22 Harmful : danger of serious damage to health
by prolonged exposure if swallowed.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 301-04-2: 2
CAS# 6080-56-4: 2
CAS# 7439-92-1: No information available.
Canada
CAS# 301-04-2 is listed on Canada's DSL List.
CAS# 7439-92-1 is listed on Canada's DSL List.
CAS# 301-04-2 is listed on Canada's Ingredient Disclosure List.
CAS# 6080-56-4 is not listed on Canada's Ingredient Disclosure List.
CAS# 7439-92-1 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 301-04-2 is listed on the TSCA inventory.
CAS# 6080-56-4 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 7439-92-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 61 May cause harm to the unborn child.
R 62 Possible risk of impaired fertility.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
MSDS Creation Date: 7/28/1998 Revision #5 Date: 7/26/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-Ascorbic acid
| 50-81-7 |
|
L-Asparagine Monohydrate
| 5794-13-8 |
|
L-Tryptophan
| 73-22-3 |
|
L-Tyrosine
| 60-18-4 |
|
L-Methionine
| 63-68-3 |
|
Methyl 5-oxazolecarboxylate, 96%
| 121432-12-0 |
|
L-Histidine
| 71-00-1 |
|
L-Histidine Hydrochloride Monohydrate
| 5934-29-2 |
|
Cycloheptatriene, 90%
| 544-25-2 |
|
2-Iodobenzyl alcohol, 99%
| 5159-41-1 |
|
5-Chlorovaleryl Chloride, 96%
| 1575-61-7 |
|
2-Nitro-p-phenylenediamine, 95-99%
| 5307-14-2 |
|
1,4-Dioxaspiro[4.5]decan-8-ol, 98+%
| 22428-87-1 |
|
Pyrazino[2,3-f]Quinoxaline, 99+%
| 231-23-2 |
|
Lanthanum chloride heptahydrate
| 10025-84-0 |
|
Lanthanum Oxide
| 1312-81-8 |
|
Lanthanum Nitrate Hexahydrate
| 10099-59-9 |
|
2,3-Pentanedione, 97%
| 600-14-6 |
|
Lauric Acid
| 143-07-7 |
|
Alpha-NPO, Scintillation Grade
| 846-63-9 |
|
4-Benzylpiperidine, 98%
| 31252-42-3 |
|
2-(2-Quinoxalinyl)malondialdehyde
| 0-00-0 |
|
4-Nitro-Benzylthiocyanate, 99%
| 13287-49-5 |
|
Methyl vinyl ketone
| 78-94-4 |
|
Lead
| 7439-92-1 |
|
2-Methoxy-5-nitroaniline, 99%
| 99-59-2 |
|
Methyltriphenylphosphonium iodide, 97%
| 2065-66-9 |
|
Lead(II) acetate trihydrate
| 301-04-2 |
|
4-Ethylbiphenyl-4'-carboxylic acid, 98%
| 5731-13-5 |
|
Mono-(Trimethylsilyl)Phosphite
| 91076-68-5 |
|
N-Acetylanthranilic acid, 99%
| 89-52-1 |
|
1,2,2,6,6-Pentamethylpiperidine, 95% (GC)
| 79-55-0 |
|
Dihydrogentrifluoride Polymer-Supported, ca 7 mMol HF/g of Amberlyst
| 12260-12-7 |
|
Lead (II) Chloride
| 7758-95-4 |
|
Triisopropanolamine borate, 98+%
| 101-00-8 |
|
(S)-3-tert.-Butyl-2,5-piperazinedione
| 65016-62-8 |
|
2-Methoxynaphthalene, 98%
| 93-04-9 |
|
Lead chromate
| 7758-97-6 |
|
1-(2'-Thienyl)Ethylmercaptan, 98%
| 94089-02-8 |
|
4-Bromobenzotrifluoride, 99%
| 402-43-7 |
|
Lead Dioxide
| 1309-60-0 |
|
N-Hydroxymaleimide, 97%
| 4814-74-8 |
|
1-Dodecanethiol, 98.5+% (gc)
| 112-55-0 |
|
2,4,6-Trimethylaniline, 97%
| 88-05-1 |
|
Iodobenzene diacetate, 98%
| 3240-34-4 |
|
Trans 2, cis 6-nonadienol, 94%
| 28069-72-9 |
|
1,5-Dihydroxy-1,2,3,4-Tetrahydro-Naphthalene, Tech.
| 40771-26-4 |
|
Acrolein dimethyl acetal, 99%
| 6044-68-4 |
|
Lead(II) nitrate
| 10099-74-8 |
|
Lead Oxide Yellow
| 1317-36-8 |
|
|